Beta Drugs (NSE:BETA) Total Tax Payable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BETA Beta Drugs Ltd NSE:BETA
96 GF Score
Price ₹2,366.90
GF Value ₹2,671.14
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Beta Drugs Total Tax Payable?

Beta Drugs NSE:BETA +0.08% 96 Total Tax Payable is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:BETA with a GF Score™ of 96/100 and a GF Value™ of ₹2,671.14 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta Drugs's Total Tax Payable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Beta Drugs Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Beta Drugs's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Drugs Total Tax Payable Chart

Beta Drugs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.89 3.34 0.00 0.00 0.00

Beta Drugs Quarterly Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:BETA
96GF Score
Beta Drugs Ltd NSE:BETA
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Drugs Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ₹0 Mil mean?
Beta Drugs (NSE:BETA) has a Total Tax Payable of ₹0 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Beta Drugs and its competitors.
Is Beta Drugs' Total Tax Payable too high?
Beta Drugs' current Total Tax Payable is ₹0 Mil. Overall, Beta Drugs has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beta Drugs' Total Tax Payable compare to ZTS?
Beta Drugs' Total Tax Payable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Beta Drugs and its competitors. Beta Drugs's current Total Tax Payable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Drugs stock overvalued right now?
Based on GuruFocus' analysis, Beta Drugs (NSE:BETA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,671.14, compared to a current price of ₹2,366.90 — trading 11.4% below its estimated fair value. The current Total Tax Payable is ₹0 Mil. Beta Drugs' overall GF Score™ is 96/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Beta Drugs (NSE:BETA), the current Total Tax Payable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beta Drugs (NSE:BETA) Overvalued in 2026?

Based on GuruFocus' analysis, Beta Drugs stock appears to be undervalued. The current stock price of ₹2,366.90 is trading 11.4% below its estimated GF Value™ of ₹2,671.14. GuruFocus considers Beta Drugs to be Modestly Undervalued.

Key valuation signals for NSE:BETA:

  • Total Tax Payable: ₹0 Mil
  • GF Value™: ₹2,671.14 vs. price of ₹2,366.90 (11.4% below fair value)
  • GF Score™: 96/100 with 6 warning signs

No single metric tells the full story. See the NSE:BETA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beta Drugs Business Description

Address SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries, of which key revenue is derived from the sales made in India.
96GF Score

Get the complete analysis for NSE:BETA

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,366.90
Price
₹2,671.14
GF Value